Drug: |
CB-839 + Talazoparib |
|||
---|---|---|---|---|
Trial: |
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Terminated |
South Texas Accelerated Research Therapeutics (START)4319 Medical Dr. |
Principal Investigator: |
|
---|---|
Contact: |
Isabel Jimenez, RN, MSN 210-593-5265 isabel.jimenez@startsa.com |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
South Texas Accelerated Research Therapeutics (START) Website: |
http://www.startthecure.com/clinical-trials.html |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.